Intra-Cellular Therapies
ITCI
#1538
Rank
โ‚น1.267 T
Marketcap
โ‚น11,897
Share price
0.00%
Change (1 day)
102.44%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Last known market cap: โ‚น1.267 Trillion

As of January 2026 Intra-Cellular Therapies has a market cap of โ‚น1.267 Trillion. This makes Intra-Cellular Therapies the world's 1538th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น1.260 T63.41%
2024โ‚น771.69 B34.49%
2023โ‚น573.79 B38.36%
2022โ‚น414.72 B30.68%
2021โ‚น317.35 B69.59%
2020โ‚น187.12 B37.79%
2019โ‚น135.80 B210.64%
2018โ‚น43.71 B-13.36%
2017โ‚น50.46 B13.73%
2016โ‚น44.36 B-71.24%
2015โ‚น154.26 B367.5%
2014โ‚น32.99 B20.52%
2013โ‚น27.38 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MediciNova
MNOV
โ‚น6.80 B-99.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚น0.95 B-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚น89.97 B-92.90%๐Ÿ‡บ๐Ÿ‡ธ USA